Toshiaki Ishida

829 total citations
51 papers, 439 citations indexed

About

Toshiaki Ishida is a scholar working on Hematology, Neurology and Molecular Biology. According to data from OpenAlex, Toshiaki Ishida has authored 51 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Neurology and 10 papers in Molecular Biology. Recurrent topics in Toshiaki Ishida's work include Neuroblastoma Research and Treatments (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). Toshiaki Ishida is often cited by papers focused on Neuroblastoma Research and Treatments (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). Toshiaki Ishida collaborates with scholars based in Japan and United States. Toshiaki Ishida's co-authors include Daiichiro Hasegawa, Yoshiyuki Kosaka, Kenji Kishimoto, Takako Miyamura, Kazuaki Chayama, Akihiro Tamura, Tsuneo Morishima, Nobuyuki Yamamoto, Kana Washio and Yoshiaki Kita and has published in prestigious journals such as Blood, British Journal of Cancer and Nutrition.

In The Last Decade

Toshiaki Ishida

46 papers receiving 433 citations

Peers

Toshiaki Ishida
Tomoo Osumi Japan
Takako Miyamura Japan
Ci Pan China
Nozomi Iwanaga Japan
Toshio Kakihara Japan
M. van Weel Netherlands
Serena Formica Italy
Francesca Scuderi Italy
Zhengrong Mao China
Ying‐Wei Lin Japan
Tomoo Osumi Japan
Toshiaki Ishida
Citations per year, relative to Toshiaki Ishida Toshiaki Ishida (= 1×) peers Tomoo Osumi

Countries citing papers authored by Toshiaki Ishida

Since Specialization
Citations

This map shows the geographic impact of Toshiaki Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Ishida more than expected).

Fields of papers citing papers by Toshiaki Ishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Ishida. The network helps show where Toshiaki Ishida may publish in the future.

Co-authorship network of co-authors of Toshiaki Ishida

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Ishida. A scholar is included among the top collaborators of Toshiaki Ishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Ishida. Toshiaki Ishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kishimoto, Kenji, Sayaka Nakamura, Toshiaki Ishida, et al.. (2024). Early eosinophilia after hematopoietic stem cell transplantation is associated with chronic graft‐versus‐host disease. Pediatrics International. 66(1). e15836–e15836.
2.
3.
Ishida, Toshiaki, Daiichiro Hasegawa, Yoshiyuki Kosaka, et al.. (2023). Catheter-related bloodstream infection caused by Tsukamurella tyrosinosolvens identified by secA1sequencing in an immunocompromised child: a case report. Annals of Clinical Microbiology and Antimicrobials. 22(1). 97–97.
4.
Ishida, Toshiaki, Daiichiro Hasegawa, Yoshiyuki Kosaka, et al.. (2023). Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high‑risk neuroblastoma: A case report. Oncology Letters. 26(3). 369–369. 1 indexed citations
5.
Hasegawa, Daiichiro, et al.. (2023). Association between conditioning intensity and height growth after allogeneic hematopoietic stem cell transplantation in children. Cancer Medicine. 12(16). 17018–17027. 1 indexed citations
6.
Ishida, Toshiaki, Akihiro Nishimura, Akihiro Tamura, et al.. (2022). Minimal residual disease detected by droplet digital PCR in peripheral blood stem cell grafts has a prognostic impact on high-risk neuroblastoma patients. Heliyon. 8(10). e10978–e10978. 2 indexed citations
7.
Tamura, Akihiro, Sayaka Nakamura, Nobuyuki Yamamoto, et al.. (2021). Early elevation of factor IX level in japanese brothers with Haemophilia B Leyden who are carrying c. ‐35 g > a mutations in the promoter region of F9. Haemophilia. 27(4). e510–e512. 2 indexed citations
8.
Ishida, Toshiaki, Nobuyuki Yamamoto, Akihiro Tamura, et al.. (2021). Minimal residual disease in high-risk neuroblastoma shows a dynamic and disease burden-dependent correlation between bone marrow and peripheral blood. Translational Oncology. 14(8). 101019–101019. 12 indexed citations
9.
Kishimoto, Kenji, Daiichiro Hasegawa, Kei Irie, et al.. (2020). Pharmacokinetic analysis for model‐supported therapeutic drug monitoring of busulfan in Japanese pediatric hematopoietic stem cell transplantation recipients. Pediatric Transplantation. 24(4). e13696–e13696. 5 indexed citations
10.
Tamura, Akihiro, Sayaka Nakamura, Toshiaki Ishida, et al.. (2020). Low Multiplication Value of Absolute Monocyte Count and Absolute Lymphocyte Count at Diagnosis May Predict Poor Prognosis in Neuroblastoma. Frontiers in Oncology. 10. 572413–572413. 4 indexed citations
11.
Tamura, Akihiro, Nobuyuki Yamamoto, Takayuki Ichikawa, et al.. (2019). Pazopanib maintenance therapy after tandem high-dose chemotherapy for disseminated Ewing sarcoma. International Cancer Conference Journal. 8(3). 95–100. 10 indexed citations
12.
13.
Tamura, Akihiro, Toshiaki Ishida, Nobuyuki Yamamoto, et al.. (2018). Low‐dose azacitidine maintenance therapy after allogeneic stem cell transplantation for high‐risk pediatric acute myeloid leukemia. Pediatric Blood & Cancer. 65(10). e27284–e27284. 14 indexed citations
14.
Tamura, Akihiro, Nobuyuki Yamamoto, Kenji Kishimoto, et al.. (2018). Hematopoietic cell transplantation for asymptomatic X-linked lymphoproliferative syndrome type 1. Allergy Asthma and Clinical Immunology. 14(1). 82–82. 2 indexed citations
15.
Tamura, Akihiro, Kousaku Matsubara, Toshiaki Ishida, et al.. (2018). Co‐occurrence of hypertrophic cardiomyopathy and juvenile myelomonocytic leukemia in a neonate with Noonan syndrome, leading to premature death. Clinical Case Reports. 6(7). 1202–1207. 2 indexed citations
16.
Tamura, Akihiro, Kenji Kishimoto, Toshiaki Ishida, et al.. (2017). Congenital immature pure erythroid leukemia with E-cadherin expression. International Journal of Hematology. 106(5). 711–717. 2 indexed citations
17.
Tamura, Akihiro, Daiichiro Hasegawa, Kenji Kishimoto, et al.. (2017). Reemergence of translocation t(11;19)(q23;p13.1) in the absence of clinically overt leukemia. International Journal of Hematology. 106(6). 847–851. 1 indexed citations
18.
Tsukahara, Hirokazu, Kazuaki Chayama, Toshiaki Ishida, et al.. (2011). Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B‐precursor acute lymphoblastic leukemia. Pediatric Blood & Cancer. 59(1). 83–89. 62 indexed citations
19.
Miyamura, Takako, Ryuichi Yoshida, Takahito Yagi, et al.. (2010). Successful treatment of unresectable advanced hepatoblastoma: Living liver transplantation after surgical removal of lung metastasis. Pediatric Transplantation. 15(5). E87–91. 5 indexed citations
20.
Miyamura, Takako, Kazuaki Chayama, Tomoaki Wada, et al.. (2008). Two cases of chronic active Epstein–Barr virus infection in which EBV‐specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation. Pediatric Transplantation. 12(5). 588–592. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoo Osumi Breakdown of academic impact, for papers by Takako Miyamura Breakdown of academic impact, for papers by Ci Pan Breakdown of academic impact, for papers by Nozomi Iwanaga Breakdown of academic impact, for papers by Toshio Kakihara Breakdown of academic impact, for papers by M. van Weel Breakdown of academic impact, for papers by Serena Formica Breakdown of academic impact, for papers by Francesca Scuderi Breakdown of academic impact, for papers by Zhengrong Mao Breakdown of academic impact, for papers by Ying‐Wei Lin
Rankless by CCL
2026